These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 1265472)
1. Activity of cephazolin and other cephalosporins against Bacteroides fragilis. Leigh DA; Simmons K Scott Med J; 1976 Sep; 20(5):228-31. PubMed ID: 1265472 [TBL] [Abstract][Full Text] [Related]
2. Clinical bacteriology of cephazolin. McAllister TA; Tait SC; Perman MG; Park AC Scott Med J; 1976 Sep; 20(5):220-7. PubMed ID: 1265471 [TBL] [Abstract][Full Text] [Related]
3. In-vitro sensitivity tests and in-vivo efficacy of cephalosporins against Bacteroides fragilis. Brook I J Antimicrob Chemother; 1990 Jul; 26(1):158-61. PubMed ID: 2211440 [No Abstract] [Full Text] [Related]
4. Comparative antibacterial activity of the new cephalosporin cefcanel against anaerobic bacteria. Nord CE; Lindmark A; Persson I Eur J Clin Microbiol Infect Dis; 1989 Jun; 8(6):550-1. PubMed ID: 2548866 [TBL] [Abstract][Full Text] [Related]
5. In vitro bactericidal activities and morphologic changes in Escherichia coli and Bacteroides fragilis by cephalosporins. Mikamo H; Kawazoe K; Sato Y; Hayasaki Y; Satoh M; Kai J; Tamaya T Chemotherapy; 1998; 44(3):157-63. PubMed ID: 9612605 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of antibacterial activities of cephalosporin antibiotics: cefazolin, cephaloridine, cephalothin, and cephalexin. Hsieh WC; Ho SW Zhonghua Min Guo Wei Sheng Wu Xue Za Zhi; 1975 Mar; 8(1):1-11. PubMed ID: 1097210 [TBL] [Abstract][Full Text] [Related]
7. The in vitro spectrum of the cephalosporins. Washington JA Mayo Clin Proc; 1976 Apr; 51(4):237-50. PubMed ID: 1263595 [TBL] [Abstract][Full Text] [Related]
8. [In vitro and in vivo antimicrobial activities of cefmetazole against Bacteroides fragilis]. Isono M; Kawashima K; Yamada N; Aoki M; Kobayashi T; Sawa K; Watanabe K; Ueno K Jpn J Antibiot; 1982 Jul; 35(7):1667-72. PubMed ID: 6757469 [TBL] [Abstract][Full Text] [Related]
9. Recovery of Bacteroides fragilis group from clinical specimens following antimicrobial therapy. Brook I; Frazier EH Can J Microbiol; 1992 Mar; 38(3):226-9. PubMed ID: 1393825 [TBL] [Abstract][Full Text] [Related]
10. Susceptibility to cefazedone and cefazolin and production of beta-lactamase in in Bacteroides fragilis and other species of Bacteroidaceae. Werner H; Krasemann C; Ungerechts J Arzneimittelforschung; 1979; 29(2a):388-92. PubMed ID: 314805 [No Abstract] [Full Text] [Related]
11. Beta-lactamase resistance of cephazolin and other cephalosporins. Goodwin CS; Hill JP Scott Med J; 1976 Sep; 20(5):236-9. PubMed ID: 772808 [TBL] [Abstract][Full Text] [Related]
13. In-vitro and in-vivo activities of a novel cephamycin MT-141 against the Bacteroides fragilis group in comparison with six cephem antibiotics. Kasai T; Hara T; Tamura A; Kazuno Y; Inouye S; Goto S; Kuwahara S J Antimicrob Chemother; 1985 Jun; 15(6):701-14. PubMed ID: 3928575 [TBL] [Abstract][Full Text] [Related]
14. [The microbiologic activity of cephalothin, cephalexin, cephacetrile, cephradine, cephazolin and cephamandol]. Knothe H; Lauer B Adv Clin Pharmacol; 1974; 8():80-8. PubMed ID: 4468733 [No Abstract] [Full Text] [Related]
15. The activity of cephalosporins on beta-lactamase-producing Neisseria gonorrhoeae. Phillips I; Shannon K Scand J Infect Dis Suppl; 1978; (13):23-6. PubMed ID: 98833 [TBL] [Abstract][Full Text] [Related]
16. Cephalosporin-resistance in the Bacteroides fragilis group and the effect of clavulanic acid. Maskell JP; Nasu M; Williams JD J Antimicrob Chemother; 1984 Jan; 13(1):23-30. PubMed ID: 6607916 [TBL] [Abstract][Full Text] [Related]